<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition>advanced colorectal cancer</condition><disease>Advanced Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2626003</full_dataset_link><location>Japan</location><study_start_month>5</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Phase II study of efficacy and safety of duloxetine for chlonic oxaliplatin-induced peripheral neuropathy in metastatic colorectal cancer</name><description>Interventions: duloxetine
Primary outcome(s): prolongation of period of oxaliplatin treatment
Study Design: Single arm Non-randomized</description><dates><creation>2013-05-15</creation></dates><accession>2626003</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000010621</Japan Primary Registries Network></cross_references></HashMap>